Sunday, April 19, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Can you tell when your provider does not trust you?

Question asked:
“How strongly do you believe that you can tell when your provider does not trust you?”

Key findings (n = 246):

  • 77% of respondents report they can tell strongly or very strongly when a provider does not trust them.

  • Only 7% report little to no ability to detect distrust.

  • 17% remain unsure, suggesting ambiguity rather than neutrality.

Interpretation:
Perceived trust is not subtle for most patients. A large majority believe they can reliably sense when a clinician doubts their honesty, adherence, or intentions. This suggests that provider trust—or lack thereof—is experienced as an emotionally salient signal, not a background variable.

A. Implications for Patients

  1. Reduced Disclosure

    • Patients who sense distrust may withhold symptoms, medication nonadherence, or social factors.

    • This increases diagnostic error and undermines shared decision-making.

  2. Emotional Withdrawal

    • Perceived distrust activates shame and defensiveness, especially in chronic pain, mental health, obesity, and substance-use contexts.

    • Patients may disengage silently rather than confront the issue.

  3. Care Avoidance

    • Repeated experiences of distrust can lead patients to delay care, switch providers, or rely on non-clinical sources (online forums, influencers).


B. Implications for Physicians

  1. Unintentional Signaling

    • Micro-behaviors (tone, interruptions, chart-focused attention, skepticism framing) may communicate distrust even when none is intended.

    • These signals often operate below conscious awareness.

  2. Clinical Efficiency Paradox

    • Distrust may feel time-saving (“cutting through the story”), but it often costs time later through repeated visits, nonadherence, and conflict.

  3. Burnout Feedback Loop

    • Distrust erodes relational satisfaction for clinicians, increasing emotional exhaustion and reinforcing cynical practice patterns.


C. System-Level Insight

  • Trust should be treated as a measurable clinical variable, not a “soft skill.”

  • Surveys like this can inform:

    • clinician training

    • patient-experience metrics

    • value-based care incentives

    • AI-assisted documentation and communication tools

 

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!